Irinotecan and mismatch repair deficiency

被引：0

作者：

Power, D. G. ^{[1
]}

Feilchenfeldt, J. ^{[2
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Gastrointestinal Oncol Div, New York, NY 10021 USA

[2] Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland

来源：

ANNALS OF ONCOLOGY | 2010年 / 21卷 / 02期

关键词：

ADVANCED COLORECTAL-CANCER; RANDOMIZED PHASE-III; MICROSATELLITE INSTABILITY; ADJUVANT; TRIAL;

D O I：

10.1093/annonc/mdp550

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 7 条

[1] Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803 [J].

Bertagnolli, Monica M. ;

Niedzwiecki, Donna ;

Compton, Carolyn C. ;

Hahn, Hejin P. ;

Hall, Margaret ;

Damas, Beatrice ;

Jewell, Scott D. ;

Mayer, Robert J. ;

Goldberg, Richard M. ;

Saltz, Leonard B. ;

Warren, Robert S. ;

Redston, Mark .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (11) :1814-1821

[2] Deficient mismatch repair system in patients with sporadic advanced colorectal cancer [J].

Koopman, M. ;

Kortman, G. A. M. ;

Mekenkamp, L. ;

Ligtenberg, M. J. L. ;

Hoogerbrugge, N. ;

Antonini, N. F. ;

Punt, C. J. A. ;

van Krieken, J. H. J. M. .

BRITISH JOURNAL OF CANCER, 2009, 100 (02) :266-273

[3] Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy.: A report of the AIO Colorectal Study Group [J].

Mueller, C. I. ;

Schulmann, K. ;

Reinacher-Schick, A. ;

Andre, N. ;

Arnold, D. ;

Tannapfel, A. ;

Arkenau, H. ;

Hahn, S. A. ;

Schmoll, S. H. -J. ;

Porschen, R. ;

Schmiegel, W. ;

Graeven, U. .

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2008, 23 (11) :1033-1039

[4]

ROTH AD, 2009, P AM SOC CLIN ONC AN

[5] Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3 [J].

Van Cutsem, Eric ;

Labianca, Roberto ;

Bodoky, Gyoery ;

Barone, Carlo ;

Aranda, Enrique ;

Nordlinger, Bernard ;

Topham, Claire ;

Tabernero, Josep ;

Andre, Thierry ;

Sobrero, Alberto F. ;

Mini, Enrico ;

Greil, Richard ;

Di Costanzo, Francesco ;

Collette, Laurence ;

Cisar, Laura ;

Zhang, Xiaoxi ;

Khayat, David ;

Bokemeyer, Carsten ;

Roth, Arnaud D. ;

Cunningham, David .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) :3117-3125

[6] A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer [J].

Ychou, M. ;

Hohenberger, W. ;

Thezenas, S. ;

Navarro, M. ;

Maurel, J. ;

Bokemeyer, C. ;

Shacham-Shmueli, E. ;

Rivera, F. ;

Choi, C. Kwok-Keung ;

Santoro, A. .

ANNALS OF ONCOLOGY, 2009, 20 (12) :1964-1970

[7] A phase III randomised trial of LV5FU2+irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802) [J].

Ychou, M. ;

Raoul, J. -L. ;

Douillard, J. -Y. ;

Gourgou-Bourgade, S. ;

Bugat, R. ;

Mineur, L. ;

Viret, F. ;

Becouarn, Y. ;

Bouche, O. ;

Gamelin, E. ;

Ducreux, M. ;

Conroy, T. ;

Seitz, J. -F. ;

Bedenne, L. ;

Kramar, A. .

ANNALS OF ONCOLOGY, 2009, 20 (04) :674-680

← 1 →